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ABSTRACT 
Aceclofenac, a non-steroidal anti-inflammatory drug has been used in the treatment of rheumatoid arthritis and osteoarthritis. In order to 
decrease the gastric ulcerogenic effects, aceclofenac hydrogel have been developed. Topical gel preparations are intended for skin application 
or to certain mucosal surfaces for local action or transdermal penetration of medicament or for their emollient or protective action. Topical 
delivery of drugs can be achieved by incorporating drug into the gel matrix for effective delivery of drugs, thus avoiding first pass metabolism 
and for increased local action in pain management and skin diseases. NSAID’s are non-steroidal drugs having excellent anti-inflammatory and 
analgesic activity but NSAID’s produces GIT ulceration, liver and kidney trouble especially in case of oral administration. In view of adverse 
drug reaction associated with oral formulations, many NSAID’s are increasingly administered by topical route. Hydrophilic polymers like Guar 
gum and Carbopol 940 of varying concentrations were used in an attempt to develop topical hydrogel formulations of aceclofenac. Evaluation 
tests for visual appearance, pH, viscosity, spreadability, assay, in vitro drug release were carried out. In vitro diffusion study was carried out in a 
Franz diffusion cell using cellophane membrane. No prominent changes in physicochemical properties of formulation were observed after 
exposure to accelerated conditions of temperature (40 ± 2oC) and humidity conditions (75 ± 5%RH). The gel formulation consisting of 1% w/v 
Guar gum 1% w/v Carbopol 940 at 1:1 ratio was found to be suitable for topical application based on in vitro evaluation. These results suggest 
the feasibility of the topical gel formulation of aceclofenac. 
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INTRODUCTION 
Osteoarthritis (OA) is the most prevalent disease after the 
age of 65 in about 60% of men and 70% of women1. OA is 
primarily a non-inflammatory degenerative joint disease 
characterized by progressive loss of articular cartilage, 
subchondrial bone sclerosis, osteophyte formation, changes 
in the synovial membrane, and an increased volume of 
synovial fluid with reduced viscosity and hence, changed 
lubrication properties. Current treatment options for OA are 
limited. They include intra-articular (IA) injection of 
glucocorticoids and hyaluronic acid (HA) preparations or 
symptomatic treatment with simple non-steroidal anti-
inflammatory drugs (NSAIDs)2. Due to the localized nature 
of the disease, the IA injection of glucocorticoids and HA 
seems to be an attractive approach for OA, but they provide 
only short-term pain relief and/or often do not provide 
adequate pain relief and have no patient compliance2. On the 
other hand, Rheumatoid arthritis (RA) is a common chronic 
systemic inflammatory disease that is primarily 
characterized by inflammation of the synovium with 
destruction of cartilage and bone as the disease progresses. 
More severe disease may be associated with vasculitis, 
pericarditis, pleural effusion, pulmonary interstitial fibrosis, 
peripheral neuropathies, subcutaneous and pulmonary 
nodules and scleritis3,4. Since there is no cure, symptomatic 
treatment is the only choice to reduce the pain and 
inflammation. Formulations of NSAIDs are the first choice 
remedies which would fulfill the need of providing 
significantly long remission of pain with improved patient 
compliance. Aceclofenac (ACF) is a non-steroidal anti-
inflammatory drug (NSAID) and has been indicated orally 
for the relief of pain and inflammation in osteoarthritis, 
rheumatoid arthritis, and ankylosing spondylitis5,6. 
However, the oral administration of ACF has often resulted 
in side effects, including gastrointestinal ulcer and anemia 
due to gastrointestinal bleeding 7. It requires frequent oral 
dosing because of its short half-life (3-4 h). Topical 
administration of ACF would be a possible alternative 
offering distinct advantages such as elimination of the 
absorption variable rate, first pass intestinal and hepatic 
metabolism inherent with oral dosing and delivering the 
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drug directly to the inflamed site and thereby, producing 
high local concentrations and avoiding the side effects8. 
Topical administration of therapeutic agents offers many 
advantages over oral and intravenous administrations. 
Hydrogel based drug delivery system is a most promising 
novel approach now-a-days for delivery of drug for extended 
period of time. Hydrogels are the three-dimensional network 
polymers that swell in aqueous solutions and in swollen 
state, these become soft and rubbery, resembling a living 
tissue and some possess excellent biocompatibility. 
Hydrogel systems possesses a good stability in surrounding 
conditions like change in pH, ionic strength, temperature 
and frequent changes of environment in the GI-tract, which 
has a variation of environment from the stomach to intestine 
9. Hydrogel from natural polymers, especially 
polysaccharides have been widely used for their advantages 
over synthetic polymers such as non-toxic, biocompatible, 
biodegradable, freely available, able to modify the properties 
of aqueous environment, capable of thicking, emulsify, 
stabilize, encapsulate and swell and to form gels films. But 
they can be modified to overcome some drawbacks, like 
uncontrolled rate of hydration, microbial contamination, 
drop in viscosity on storing, etc 10. In present work, attempt 
was made to formulate and evaluate topical hydrogel drug 
delivery systems. Attempts were made to enhance drug 
absorption and exposure to improve therapy by controlling 
the rate of drug release from dosage forms. Rate of drug 
release was modified using cross-linking agents, gelling or 
thickening agents. The ultimate aim was to improve 
bioavailability of the drug and to improve the market 
formulation by the use of combination of hydrophilic 
polymers. 
MATERIALS AND METHODS 
Materials 
Aceclofenac was obtained as a gift sample from Yarrow 
Chemical Ltd, Bombay.  Carbopol- 940 (Loba Chemie Pvt. 
Ltd., Mumbai, India), Guargum (Qualigens Fine Chemicals, 
Mumbai, India), Benzalkonium chloride (Prime laboratories, 
Hyderabad), Isopropyl myristate (Alpha Chemika, 
Maharashtra, India), sodium hydroxide (Prime laboratories, 
Hyderabad), potassium dihydrogen phosphate (Alpha 
Chemika, Maharashtra, India ) were procured and used in 
this investigation. All other chemicals used were of analytical 
grade and were used without any further chemical 
modification. 
Determination of λ max of ACF 
Accurately weighed 10 mg of drug was dissolved in 10 ml of 
7.4 pH buffer solution in 10 ml of volumetric flask. The 
resulted solution 1000µg/ml and from this solution 1 ml 
pipette out and transfer into 10 ml volumetric flask and 
volume make up with 7.4 pH buffer solution.  Prepare 
suitable dilution to make it to a concentration range of 5-
25μg/ml. The spectrum of this solution was run in 200-400 
nm range in U.V. spectrophotometer. A graph of 
concentration Vs absorbance was plotted. 
Formulation of aceclofenac topical hydrogel 
Hydrophilic polymers like guar gum and carbopol 940 were 
selected and 0.1N NaOH solution used as cross linking 
agent11,12. Carbopol 940 is soluble in water while guar gum 
produces colloidal dispersion in water. 0.1-5% w/v 
concentrations of polymeric dispersions were made 
separately and were found to be having good mechanical 
properties when guar gum and carbopol 940 colloidal 
dispersions mixed in certain proportions.  
The topical hydrogels using different proportions were 
prepared as follows: 
1. Hydrogels were fabricated using different concentrations 
of polymeric dispersions.  
2. Different concentrations of carbopol940 colloidal 
dispersions were prepared using distilled water.  
3. Different concentrations of guar gum colloidal dispersions 
were prepared using distilled water.  
4. After complete dispersion, both the polymer solutions 
were kept in dark for 24 h for complete swelling.  
5. Dispersions of polymers were made using magnetic stirrer 
(500rpm). After dispersing carbopol940 in distilled water, 
colloidal dispersion of guar gum was added to it under 
magnetic stirring. 1% v/v isopropyl myristate and 0.25% 
w/v benzalkonium chloride were added. Aqueous drug 
solution was added to the polymeric dispersion after 
addition of sodium hydroxide solution. Finally, the 
remaining distilled water was added to obtain a 
homogeneous dispersion of gel under magnetic stirring. The 
composition of different formulation was given in Table 1.
 
Table 1 Different formulas of aceclofenac hydrogel  
Ingredients (Mg) Formulation Code   
      
F1 F2 F3 F4 F5 
      
Aceclofenac 100 100 100 100 100 
      
Carbopol-940 0.375 0.5 0.25 0.375 0.5 
      
Guar gum 0.05 0.5 0.375 0.375 0.375 
      
Isopropyl myristate (ml) 1 1 1 1 1 
      
Benzalkonium chloride 0.25 0.25 0.25 0.25 0.25 
      
Purified water (q.s) 100ml 100ml 100ml 100ml 100ml 
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Evaluation of hydrogel  
Physical characteristic  
The prepared hydrogel formulations were inspected visually 
for their pH, colour, homogeneity, consistency, grittiness, 
texture and phase separation 
Determination of pH  
The pH of hydrogel formulations was determined by digital 
pH meter. One gram of gel was dissolved in 25 ml of distilled 
water and the electrode was then dipped in to gel 
formulation for 30 min until constant reading obtained.  And 
constant reading was noted. The measurement of pH of each 
formulation was done in triplicate and average values were 
calculated13. 
Washability  
Formulations were applied on the skin and then ease and 
extent of washing with water were checked manually. 
Extrudability study  
The hydrogel formulations were filled into collapsible metal 
tubes or aluminium collapsible tubes. The tubes were 
pressed to extrude the material and the extrudability of the 
formulation was checked14.  
Spreadability  
Two glass slides of standard dimensions (6×2) were 
selected. The hydrogel formulation whose spreadability had 
to be determined was placed over one of the slides. The 
second slide was placed over the slide in such a way that the 
formulation was sandwiched between them across a length 
of 6 cms along the slide. 100 grams of weight was placed up 
on the upper slide so that the hydrogel formulation between 
the two slides was traced uniformly to form a thin layer. The 
weight was removed and the excess of the hydrogel 
formulation adhering to the slides was scrapped off. The 
lower slide was fixed on the board of the apparatus and one 
end of the upper slide was tied to a string to which 20 gram 
load could be applied with the help of a simple pulley. The 
time taken for the upper slide to travel the distance of 6 cms 
and separate away from lower slide under the direction of 
the weight was noted. The experiment was repeated and the 
average of 6 such determinations was calculated for each 
hydrogel formulation 15,16. 
 
   Where, S=Spreadability (gcm/sec), m = weight tied to the 
upper slide (20 grams),  
    l= length of glass slide (6cms),   t = time taken is seconds. 
Viscosity  
The measurement of viscosity of the prepared hydrogel was 
done using Brookfield digital Viscometer. The viscosity was 
measured using spindle no. 6 at 10 rpm and 250C. The 
sufficient quantity of gel was filled in appropriate wide 
mouth container. The hydrogel was  filled  in  the  wide  
mouth  container in such way that it should  sufficiently  
allow  to  dip  the  spindle of the viscometer. Samples of the 
hydrogel were allowed to settle over 30 min at the constant 
temperature (25 ±/10C) before the measurements17.  
Drug content  
Accurately weighed equivalent to100 mg of topical hydrogel 
was taken in beaker and added 20 ml of phosphate buffer pH 
7.4. This solution was mixed thoroughly and filtered using 
Whatman filter paper no.1. Then 1.0 ml of filtered solution 
was taken in 10 ml capacity of volumetric flask and volume 
was made upto 10 ml with phosphate buffer pH 7.4. This 
solution was analyzed using UV spectrophotometer at λmax 
275 nm.  
In-vitro drug release studies using the prehydrated 
cellophane membrane 
The prepared hydrogel was evaluated for in vitro drug 
release. In vitro diffusion study was carried out in a Franz 
diffusion cell using cellophane membrane. The cellophane 
membrane was mounted on the Franz diffusion cell. 
Formulation was applied through donor compartment on 
the dialysis membrane. Reservoir compartment was filled 
with 25 ml phosphate buffer of pH 7.4 The study was carried 
out at 37 ± 1°C and at a speed of 100 rpm for 8  h. Samples 
were withdrawn from reservoir compartment at 1 h interval 
and absorbance was measured spectrophotometrically at 
275.0 nm. Each time the reservoir compartment was 
replenished with the same quantity of 7.4 pH phosphate 
buffer 18,19. 
Accelerated stability studies 
Stability studies were carried out on optimized formulation 
according to International Conference on Harmonization 
(ICH) guidelines. The formulation packed in aluminium tube 
was subjected to accelerated stability testing for 3 months as 
per ICH norms at a temperature (40 ± 2oC) and relative 
humidity 75 ± 5%. Samples were taken at regular time 
intervals of 1month for over a period of 3months and 
analyzed for the change in pH, spreadability, drug content 
and in-vitro drug release by procedure stated earlier. Any 
changes in evaluation parameters, if observed were noted. 
Tests were carried out in triplicate and mean value of the 
observed values was noted along with standard deviation. 
RESULTS AND DISCUSSIONS 
The absorption maxima of ACF were determined by running 
the spectrum of drug solution in double beam ultraviolet 
spectrophotometer using concentration range of 5-25μg/ml 
ACF in 7.4phosphate buffers. ACF showed a linear 
relationship with correlation coefficient of 0.999 in the 
concentration range of 5-25μg/ml in phosphate buffer pH 
7.4 Figure1. Melting point of drug was found 148-1490C 
while it was 149-150°C reported in standard monograph. All 
the data of preformulation study were found similar as given 
in standard monograph which confirmed that the drug was 
authenticated and pure in form and it could be used for 
formulation development of ACF -loaded hydrogel. 
 
Fig.1 Calibration curve of ACF in phosphate buffer pH 7.4 
at 275nm 
Hydrogel formulations were white viscous creamy 
preparation with a smooth homogeneous texture and glossy 
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appearance. Results have been discussed in Table 2. The 
results of washability, extrudability and spreadability of all 
formulation were given in Table 3. From the result it was 
found that formulation F1-F5 has good washability ability, 
formulation F2, F3 has good Extrudability and Spreadability 
of all formulation was found to in range of 12.25to14.56. The 
viscosity of the hydrogel was obtained by using brookfield 
digital viscometer. The viscosity of the formulations 
increases as concentration of polymer increases and pH of 
prepared hydrogel were measured by using pH meter (Orion 
Research, Inc., USA). The pH of the hydrogel formulation was 
in the range of 6.95 to7.05 which considered acceptable to 
avoid the risk of skin irritation upon application to skin  and 
drug content of  F2 was found to be higher 99.7 table 4.
 
Table 2 Physical parameter of formulation batches 
Formulation Colour Homogeneity Consistency Phase separation 
F1 White Excellent Excellent None 
F2 White Excellent Excellent None 
F3 White Excellent Excellent None 
F4 White Excellent Excellent None 
F5 White Excellent Excellent None 
 
Table 3 Result of washability extrudability and spreadability study 
Formulation Washability Extrudability 
Spreadability 
(gcm/sec) 
F1 +++ ++ 12.25  
F2 +++ +++ 13.36 
F3 +++ +++ 14.56 
F4 +++ ++ 13.23 
F5 +++ ++ 14.56 
Excellent: +++, Good: ++, Average: +, Poor: - 
Table 4 viscosity,  pH and drug content 
Formulation Viscosity (cps) pH Drug Content 
F1 9344± 2 7.05 98.5 ± 0.2 
F2 9589± 2 7.02 99.7 ± 0.1 
F3 9436± 1.5 6.95 99.5 ± 0.2 
F4 9242± 2.5 6.98 99.4 ± 0.1 
F5 9180± 1.5 7.05 99.2 ± 0.3 
 
Release of drug from ACF hydrogel was significantly slower, 
which confirmed that slight prolonged drug release rate. 
Incorporation of carbomer affected the release rate of the 
drug. By increasing the amount of carbomer, the release rate 
of the drug decreased, which could be related to the 
increased rigidity of the formulation, followed by its 
decreased permeability for the drug. Optimized formulation 
F2 shows significantly improved in drug release rate as 
compare to marketed preparation. It was concluded that 
developed formulations deliver the drug for the treatment of 
OA Table 5. 
 
Table 5 % Cum. drug release of formulation F1-F5 
Time (min) Cumulative % of drug release       
                
 F1   F2   F3  F4 F5  Marketed 
              
5 73.2 ± 0.3  29.3 ± 0.4  75.6 ± 0.5 52±1 45.9 ± 0.7 42.23 
              
10 74.3 ± 0.2  38.0 ± 0.3  79.7 ± 0.2 58.4 ± 0.4 57.2 ± 0.05 65.56 
              
15 76.4 ± 0.1  39.6 ± 0.3  81.4 ± 0.4 71.3 ± 0.2 64.3 ± 0.2 76.89 
              
20 77.9 ± 0.1  47.9 ± 0.7  81.6 ± 0.2 73.4± 0.4 68.6 ± 0.5 - 
              
30 80.8 ± 0.3  88.2 ± 0.5  82.6 ± 0.6 80.5 ± 0.3 75.1 ± 0.3 - 
           
 
changes were not noticed. The formulation F2 was found to be stable after exposure to accelerated temperature and humidity 
conditions for a period of 3 months. No significant changes were seen in physical evaluation parameters and given in the table 
6.  
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Table 6 Physical parameters after accelerated stability study of formulation F2 
Physical Parameter 
Temperature:  40  ±2oC  ;Relative  humidity (RH):  75 ±5%RH 
 
 
  
   
 Initial After 1 month After 2 month After 3 month 
     
pH 7 ±0.06 6.9 ± 0.06 6.9 ± 0.06 6.9 ± 0.06 
     
Assay 99.6 ± 0.1 99.5 ± 0.1 99.4 ± 0.1 99.3 ± 0.1 
     
Viscosity 9589 ± 2 9591± 1.7 9595 ± 2 9597 ± 2.3 
     
 
 
CONCLUSION 
The Aceclofenac hydrogel for topical application was 
formulated using guar gum and Carbopol 940 and evaluation 
tests were performed. Proper selection of polymers and their 
proportions is a prerequisite for designing and developing a 
transdermal drug delivery system. The formulated gels 
showed good homogeneity, good stability and better drug 
release rates when compared to marketed formulation. 
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